Next Article in Journal
Diversity of tRNA Clusters in the Chloroviruses
Previous Article in Journal
Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT Proteins
Previous Article in Special Issue
Parenterally Administered Porcine Epidemic Diarrhea Virus-Like Particle-Based Vaccine Formulated with CCL25/28 Chemokines Induces Systemic and Mucosal Immune Protectivity in Pigs
Open AccessReview

Viral Related Tools against SARS-CoV-2

Microbiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), 15006 A Coruña, Spain
Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) of Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), 28003 Madrid, Spain
Spanish Network for the Research in Infectious Diseases (REIPI), 41071 Sevilla, Spain
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Viruses 2020, 12(10), 1172;
Received: 18 September 2020 / Revised: 14 October 2020 / Accepted: 15 October 2020 / Published: 16 October 2020
(This article belongs to the Special Issue The Application of Viruses to Biotechnology)
At the end of 2019, a new disease appeared and spread all over the world, the COVID-19, produced by the coronavirus SARS-CoV-2. As a consequence of this worldwide health crisis, the scientific community began to redirect their knowledge and resources to fight against it. Here we summarize the recent research on viruses employed as therapy and diagnostic of COVID-19: (i) viral-vector vaccines both in clinical trials and pre-clinical phases; (ii) the use of bacteriophages to find antibodies specific to this virus and some studies of how to use the bacteriophages themselves as a treatment against viral diseases; and finally, (iii) the use of CRISPR-Cas technology both to obtain a fast precise diagnose of the patient and also the possible use of this technology as a cure. View Full-Text
Keywords: SARS-CoV-2; COVID-19; phages; CRISPR; viruses; prevention; diagnosis; treatment SARS-CoV-2; COVID-19; phages; CRISPR; viruses; prevention; diagnosis; treatment
Show Figures

Graphical abstract

MDPI and ACS Style

Fernandez-Garcia, L.; Pacios, O.; González-Bardanca, M.; Blasco, L.; Bleriot, I.; Ambroa, A.; López, M.; Bou, G.; Tomás, M. Viral Related Tools against SARS-CoV-2. Viruses 2020, 12, 1172.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop